Results 221 to 230 of about 44,698 (301)

Data from Development of a [⁸⁹Zr]Zr-labeled Human Antibody using a Novel Phage-displayed Human scFv Library

Abhay K. Singh, Calvin D. Lewis, Cristian A.W.V. Boas, Philipp Diebolder, Prashant N. Jethva, Aaron Rhee, Jong Hee Song, Young Ah Goo, Shunqian Li, Michael L. Nickels, Yongjian Liu, Buck E. Rogers, Vaishali Kapoor, Dennis E. Hallahan   +13 more
openalex   +1 more source

Genetically platform presenting CD24 ScFv enhance antitumor immunity by restoring macrophage phagocytosis and modulating the immune environment. [PDF]

Cell Commun Signal
Zhou G, Gu Y, Zhang M, Zhou H, Li Y, Lin X, Lu G, Shen F, Xu C, Hua K, Ding J.   +10 more
europepmc   +1 more source

Exceptionally long CDR3H of bovine scFv antigenized with BoHV-1 B-epitope generates specific immune response against the targeted epitope

, 2016
Yfke Pasman, Caroline Soliman, Paul A. Ramsland, Azad Kaushik   +3 more
openalex   +1 more source

AI-assisted protein design to rapidly convert antibody sequences to intrabodies targeting diverse peptides and histone modifications. [PDF]

Sci Adv
Galindo G, Maejima D, DeRoo J, Burlingham SR, Fixen G, Morisaki T, Febvre HP, Hasbrook R, Zhao N, Ghosh S, Mayton EH, Snow CD, Geiss BJ, Ohkawa Y, Sato Y, Kimura H, Stasevich TJ.   +16 more
europepmc   +1 more source

From <i>Ex Vivo</i> to <i>In Vivo</i>: Advances in Lentiviral Vector Engineering for CAR-T Therapy. [PDF]

Immune Netw
Baek Y, Seo YR, Kim S, Jung S, Kim CH, Lee YH.   +5 more
europepmc   +1 more source

Combination of hu-PBL-SCID mice and scFv phage display library, an effective alternative for hu-mAb production

, 2001
Hai P. Nguyen
openalex   +1 more source

A novel SadP-scFv UCHT1 lectibody activates T cells and mediates lysis of Burkitt's lymphoma cells. [PDF]

RSC Chem Biol
Tomisch J, Gräber J, Makshakova ON, Salavei P, Rosato F, Mariscal SF, Varrot A, Imberty A, Römer W.   +8 more
europepmc   +1 more source

Development of production methodologies for scFv-Fc conjugated critical reagents to support CAR-T clinical programs. [PDF]

Bioanalysis
O'Connor E, Lachacz E, Delmar J, D'souza B, Edwards S, Griffin C, Lin R, Mody N, Salas A, Schoch-Lopez N, Shah M, Shih A, van Dyk D, Xu Y.   +13 more
europepmc   +1 more source

Advancing Cancer Immunotherapy: Chimeric Antigen Receptor (CAR)-T Cell Engineering through Novel Screening Methods. [PDF]

Biomol Ther (Seoul)
Ha J, Seong J.
europepmc   +1 more source